TWiV 1084: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin discusses the how the pandemic influenced the healthcare job market before he reviews most recent statistics on the circulation of respiratory syncytial virus, influenza virus and SARS-CoV-2 virus, including all circulating variants in the US, discusses the safety of the prefusion RSV vaccine, if high or moderate dose of the quadrivalent influenza vaccine is better for protection against hospitalization, summarizes the new WHO COVID guidelines, revisits how to prevent pathogen transmission in healthcare setting, the under use of COVID oral antiviral and what occurs in persistently...
Source: This Week in Virology - MP3 Edition - February 3, 2024 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
TWiV 1082: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin reviews most recent statistics on the circulation of respiratory syncytial virus, influenza virus and SARS-CoV-2 virus, including all circulating variants in the US, before discussing viral transmission to adults in healthcare setting, the recently EUA approved protein based COBREVAX vaccine, reviews quarantine guidelines, the use of simnotrelivr for mild to moderate COVID-19, how viral RNA may persist in your cell culture dish following antiviral therapy, continues to dispel the myth of viral rebound, how to pay for Paxlovid, , when to use steroids and the benefits of convalescen...
Source: This Week in Virology - MP3 Edition - January 27, 2024 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
TWiV 1074: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin discusses the outcomes of SARS-CoV-2, influenza and respiratory syncytial virus infection in pediatric communities under the age of 18 years, the treatment of infants with the human monoclonal anti-respiratory syncytial virus antibody to prevent hospitalizations, most recent statistics on the circulation of respiratory syncytial virus, influenza virus and SARS-CoV-2 virus in the US, how the SARS-CoV-2/COVID-19 pandemic affected school attendance and child healthcare, how exposure length influenced transmission of SARS-CoV-2, how the durability of the anti-SARS-CoV-2 antibody respo...
Source: This Week in Virology - MP3 Edition - December 30, 2023 Category: Virology Authors: VIncent Racaniello Source Type: podcasts
TWiV 1062: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin discusses coverage with selected vaccines and exemption from school vaccine requirements among children in kindergarten, seasonality of endemic COVID-19, mRNA SARS-CoV-2 vaccination before vs during pregnancy and omicron infection among infants, extracting symptoms from free-text responses using ChatGPT among COVID-19 cases in Hong Kong, SARS-CoV-2 virologic rebound with nirmatrelvir–ritonavir therapy, optimization of antiviral therapy in immunocompromised COVID-19 patients, a study to learn about the study medicines (nirmatrelvir plus ritonavir) in people aged 12 years or older...
Source: This Week in Virology - MP3 Edition - November 18, 2023 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Roy F. Chemaly, MD, MPH, FIDSA, FACP - Managing CMV in the New Era of Antiviral Therapy: Practical Considerations in the HCT Setting
Go online to PeerView.com/JVG860 to view the entire program with slides. Effective antiviral prophylaxis and therapy for opportunistic human cytomegalovirus (CMV) infection in transplant recipients and other immunocompromised hosts has long relied mainly on ganciclovir and its oral prodrug valganciclovir, with foscarnet and cidofovir in secondary roles. Use of these viral DNA polymerase inhibitors has improved clinical outcomes, particularly when used as prophylaxis or preventive therapy, but their use is associated with well-known limitations of toxicity as well as cross-resistance due to the same antiviral drug target. H...
Source: PeerView CME/CE Audio Podcast - Oncology - April 3, 2019 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Eric Lawitz, MD, AGAF, CPI - Is Warehousing Over? Exploring Recent Developments in Direct-Acting Antiviral Therapy for HCV
Is Warehousing Over? Exploring Recent Developments in Direct-Acting Antiviral Therapy for HCV (Source: PeerView CME/CE Audio Podcast - Primary Care)
Source: PeerView CME/CE Audio Podcast - Primary Care - September 9, 2014 Category: Primary Care Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Keeping Hijackers at Bay: Novel Targets for Antivirals
Advances in our understanding of how viruses hijack host cell machinery has opened new avenues of research in antiviral therapy development. How might this affect patients with infectious diseases? (Source: Medscape HIV AIDS Podcast)
Source: Medscape HIV AIDS Podcast - November 7, 2012 Category: HIV AIDS Authors: Medscape Source Type: podcasts
HIV …chronic disease management
Justin Denholm discusses the current issues in long term management of patients living with HIV. Patients with HIV treated with combination antiviral therapy (cART) now often have rapid and sustained control of HIV viraemia (often to undetectable levels) and a sustained increase in CD4+ T-cell counts. This has resulted in decreased opportunistic infections and increased longevity. Management has therefore shifted more to a chronic disease management model, in which GPs are able to provide an important role. Management focuses on the effects of HIV and its treatment on long term health, the psychosocial impact of living wit...
Source: Australian Family Physician audio - July 31, 2009 Category: Primary Care Authors: The Royal Australian College Of General Practitioners Tags: Podcasts Source Type: podcasts
HIV…chronic disease management
Justin Denholm discusses the current issues in long term management of patients living with HIV. Patients with HIV treated with combination antiviral therapy (cART) now often have rapid and sustained control of HIV viraemia (often to undetectable levels) and a sustained increase in CD4+ T-cell counts. This has resulted in decreased opportunistic infections and increased longevity. Management has therefore shifted more to a chronic disease management model, in which GPs are able to provide an important role. Management focuses on the effects of HIV and its treatment on long term health, the psychosocial impact of living wit...
Source: Australian Family Physician audio - July 31, 2009 Category: Primary Care Authors: The Royal Australian College Of General Practitioners Tags: Podcasts Source Type: podcasts
